SCM
AVLN

Sterling Capital Management’s Avalyn Pharma AVLN Stock Holding History

Sterling Capital Management’s Portfolio AVLN Stock Details AVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.91K Buy
+149
New +$4.3K ﹤0.01% 2625

Other funds holding AVLN

AP
Andera Partners Paris $206M AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Sterling Capital Management's AVLN Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Avalyn Pharma (AVLN) in Q2 2026: 149 shares worth $4.91K. The stake represents ﹤0.01% of the portfolio and ranks #2625 among its holdings.

11 funds tracked by Wall St. Rank hold AVLN as of Q2 2026.

  • Sterling Capital Management held 149 shares of Avalyn Pharma worth $4.91K as of Q2 2026.
  • Avalyn Pharma was a new Sterling Capital Management position in Q2 2026.
  • Avalyn Pharma made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2625 holding.
  • 11 funds tracked by Wall St. Rank held Avalyn Pharma as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.